Moreover, inhibition of enzymatic activity of COX-2 may delay disease onset and ameliorate the survival of ALS mice [45, 46], suggesting that chronic activation of M1 microglia and concomitant upregulation of Cox-2 caused by loss of CREST contribute to ALS pathogenesis. This evidence concerns the gene SS18L1 and amyotrophic lateral sclerosis.